Search by Drug Name or NDC
NDC 65219-0434-20 Piperacillin and Tazobactam 2; .25 g/10mL; g/10mL Details
Piperacillin and Tazobactam 2; .25 g/10mL; g/10mL
Piperacillin and Tazobactam is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is PIPERACILLIN SODIUM; TAZOBACTAM SODIUM.
MedlinePlus Drug Summary
Piperacillin and tazobactam injection is used to treat pneumonia and skin, gynecological, and abdominal (stomach area) infections caused by bacteria. Piperacillin is in a class of medications called penicillin antibiotics. It works by killing bacteria that cause infection. Tazobactam is in a class called beta-lactamase inhibitor. It works by preventing bacteria from destroying piperacillin. Antibiotics such as piperacillin and tazobactam injection will not work for colds, flu, or other viral infections. Taking or using antibiotics when they are not needed increases your risk of getting an infection later that resists antibiotic treatment.
Related Packages: 65219-0434-20Last Updated: 04/28/2024
MedLinePlus Full Drug Details: Piperacillin and Tazobactam Injection
Product Information
| NDC | 65219-0434 |
|---|---|
| Product ID | 65219-434_fc5fb491-5c91-4c60-a6a0-218d3da38d38 |
| Associated GPIs | |
| GCN Sequence Number | 021185 |
| GCN Sequence Number Description | piperacillin sodium/tazobactam VIAL 2.25 G INTRAVEN |
| HIC3 | W1A |
| HIC3 Description | PENICILLIN ANTIBIOTICS |
| GCN | 53280 |
| HICL Sequence Number | 008738 |
| HICL Sequence Number Description | PIPERACILLIN SODIUM/TAZOBACTAM SODIUM |
| Brand/Generic | Generic |
| Proprietary Name | Piperacillin and Tazobactam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Piperacillin and Tazobactam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2; .25 |
| Active Ingredient Units | g/10mL; g/10mL |
| Substance Name | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203719 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65219-0434-20 (65219043420)
| NDC Package Code | 65219-434-20 |
|---|---|
| Billing NDC | 65219043420 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-434-20) / 10 mL in 1 VIAL, SINGLE-DOSE (65219-434-02) |
| Marketing Start Date | 2023-03-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |